What is it about?

We made new compounds that appear to have a better safety profile when tested in mice.

Featured Image

Why is it important?

Reducing effects on the immune system would be safer, especially for the aging population.

Perspectives

Drugs that are safer may do a better job for treating aging disorders, especially those that affect the brain.

Ruth Perez
R & R Perez LLC

Read the Original

This page is a summary of: FTY720-derivatives do not induce FTY720-like lymphopenia, Journal of Pharmacological Sciences, March 2017, Elsevier,
DOI: 10.1016/j.jphs.2017.02.006.
You can read the full text:

Read

Contributors

The following have contributed to this page